IDiyas

For the Inventor, By the Inventor

Seoul, South Korea

Yoon Jeong Park

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 73(Granted Patents)


Company Filing History:

goldMedal12 out of 1,557 
 
Seoul National University
 patents
silverMedal12 out of 19 
 
Nano Intelligent Biomedical Engineering Corporation Co. Ltd.
 patents
bronzeMedal3 out of 4 
 
Nibec Co., Ltd.
 patents
4. 2 out of 547 
 
Snur & Db Foundation
 patents
5. 1 out of 3,370 
 
University of Michigan
 patents
6. 1 out of 43 
 
Chungbuk National University Industry-academic Cooperation Foundation
 patents
where one patent can have more than one assignee

Years Active: 2008-2023

Loading Chart...
Loading Chart...
17 patents (USPTO):
1. 11760792 - GRP78-derived peptide for identifying high-efficiency stem cells (2023-09-19),
2. 11384120 - Peptide capable of binding to biomarker for inflammatory and metabolic diseases, and use thereof (2022-07-12),
3. 11365218 - Bifunctional peptide having capability to reduce inflammation and capability to facilitate differentiation of stem cells into chondrocytes and use thereof (2022-06-21),
4. 11179445 - Pharmaceutical composition and biomaterial comprising fusion peptide in which bone tissue-selective peptide bound to parathyroid hormone (PTH) or fragment thereof (2021-11-23),
5. 10836795 - Dual functional novel peptide having cell permeability and bone tissue regeneration ability, and use thereof (2020-11-17),
6. 10821065 - Peptide for inhibiting biofilms (2020-11-03),
7. 10815312 - Bifunctional peptide having capability to permeate cells and capability to regenerate muscles and use thereof (2020-10-27),
8. 10406264 - Peptide having titanium-binding ability (2019-09-10),
9. 10232083 - Mimetic tissue structure containing extracellular matrix protein-bone mineral complex and method for manufacturing same (2019-03-19),
10. 10155022 - Fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same (2018-12-18),
11. 10066212 - Method for preparing induced pluripotent stem cells using synthetic peptide (2018-09-04),
12. 9993519 - Anticancer peptide for inhibiting proliferation of cancer stem cells and use thereof (2018-06-12),
13. 9849190 - Peptide having cancer selective translocation function and use thereof (2017-12-26),
14. 9801973 - Peptide having zirconia-binding capacity (2017-10-31),
15. 9644185 - Cell permeable fusion protein for facilitating reprogramming induction and use thereof (2017-05-09),

Title: Innovator Spotlight: Yoon Jeong Park

Introduction:

Yoon Jeong Park is a visionary inventor based in Seoul, South Korea, with an impressive portfolio of 17 patents. His groundbreaking work in stem cell research and disease treatment has garnered recognition worldwide for its potential to revolutionize the field of biomedicine.

Latest Patents:

Yoon Jeong Park's latest patents showcase his innovative approach to identifying high-efficiency stem cells and developing peptides for treating inflammatory and metabolic diseases. The GRP78-derived peptide he invented allows for the screening of potent stem cells, while the ATF3-binding peptide shows promise in treating various diseases effectively.

Career Highlights:

Yoon Jeong Park has made significant contributions to the medical and biomedical sectors through his affiliations with renowned institutions and companies. He has held key positions at Nano Intelligent Biomedical Engineering Corporation Co. Ltd. and the Seoul National University R&db Foundation, where he has spearheaded groundbreaking research projects and initiatives.

Collaborations:

Throughout his career, Yoon Jeong Park has collaborated with esteemed professionals in the field, including his coworkers Chong-Pyoung Chung and Jue-Yeon Lee. These collaborations have led to the development of innovative solutions and advancements in stem cell research and disease treatment methods.

Conclusion:

In conclusion, Yoon Jeong Park's passion for innovation and his dedication to improving healthcare have positioned him as a trailblazer in the field of biomedicine. His patents and contributions continue to shape the future of medical research and hold promise for addressing critical health challenges globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…